AU6421598A - Inhibitors for the formation of glycosylated protein denaturation produc ts - Google Patents

Inhibitors for the formation of glycosylated protein denaturation produc ts

Info

Publication number
AU6421598A
AU6421598A AU64215/98A AU6421598A AU6421598A AU 6421598 A AU6421598 A AU 6421598A AU 64215/98 A AU64215/98 A AU 64215/98A AU 6421598 A AU6421598 A AU 6421598A AU 6421598 A AU6421598 A AU 6421598A
Authority
AU
Australia
Prior art keywords
produc
inhibitors
formation
protein denaturation
glycosylated protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU64215/98A
Inventor
Toshiaki Akira
Takashi Awata
Toru Kawamura
Tomoyuki Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mitsubishi Tanabe Pharma Corp
Original Assignee
GREEN CROSS CORP
Senju Pharmaceutical Co Ltd
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GREEN CROSS CORP, Senju Pharmaceutical Co Ltd, Green Cross Corp Japan filed Critical GREEN CROSS CORP
Publication of AU6421598A publication Critical patent/AU6421598A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
AU64215/98A 1997-03-31 1998-03-20 Inhibitors for the formation of glycosylated protein denaturation produc ts Abandoned AU6421598A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP07963697A JP2003119142A (en) 1997-03-31 1997-03-31 Agent for inhibiting formation of advanced glycation end product
JP9-79636 1997-03-31
PCT/JP1998/001250 WO1998043645A1 (en) 1997-03-31 1998-03-20 Inhibitors for the formation of glycosylated protein denaturation products

Publications (1)

Publication Number Publication Date
AU6421598A true AU6421598A (en) 1998-10-22

Family

ID=13695590

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64215/98A Abandoned AU6421598A (en) 1997-03-31 1998-03-20 Inhibitors for the formation of glycosylated protein denaturation produc ts

Country Status (3)

Country Link
JP (1) JP2003119142A (en)
AU (1) AU6421598A (en)
WO (1) WO1998043645A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355680B1 (en) 1996-02-20 2002-03-12 Exocell, Inc. Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914455A1 (en) * 1990-12-27 1992-07-01 Green Cross Corp 1,4-benzothiazine-2-acetic acid derivatives, processes for production thereof
JPH08157473A (en) * 1994-10-06 1996-06-18 Nissan Chem Ind Ltd Pyrazole-based thiazolidines

Also Published As

Publication number Publication date
JP2003119142A (en) 2003-04-23
WO1998043645A1 (en) 1998-10-08

Similar Documents

Publication Publication Date Title
AU5324996A (en) Protein kinase c inhibitors
AU7631496A (en) Substituted 2-anilinopyrimidines useful as protein kinase inhibitors
AU2396897A (en) 5-aminopyrazoles useful as selective inhibitors of the protein tyrosine kinase p56ick
AU2434199A (en) Protein
AU5395299A (en) Modified soy protein adhesives
AU2805897A (en) Inhibitors of protein farnesyltransferase
AU7371998A (en) Inhibitors of protein isoprenyl transferases
AU1550300A (en) Antigen-binding proteins
AU3562299A (en) Inhibin-hbc fusion protein
AU6721696A (en) Cd44-like protein
AU6882598A (en) Protein kinase inhibitor
AU1631000A (en) Immunoglobulin superfamily proteins
AU5340399A (en) Proteases and associated proteins
AU7829700A (en) Protein phosphatase and kinase proteins
AU6760798A (en) Bax inhibitor proteins
AU7976894A (en) Solventless protein assay standard
AU2591299A (en) Human protein kinase c inhibitor
AU2071799A (en) Placental protein 13
AU2452301A (en) Protein methylarginine-specific antibodies
AU5131699A (en) Cryogranulation of activated protein c
AU6000698A (en) Proteins
AU6421598A (en) Inhibitors for the formation of glycosylated protein denaturation produc ts
AU6275098A (en) Novel h-rev 107-like protein
AU2590099A (en) Protein folding inhibitors
AU2538899A (en) Protein kinase c